AP4E1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.413810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.283000E-01
Normal-vs-Stage2
1.626610E-01
Normal-vs-Stage3
6.164200E-02
Normal-vs-Stage4
2.190000E-01
Stage1-vs-Stage2
4.863200E-01
Stage1-vs-Stage3
4.316400E-02
Stage1-vs-Stage4
2.929200E-01
Stage2-vs-Stage3
1.324220E-01
Stage2-vs-Stage4
5.304000E-01
Stage3-vs-Stage4
4.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.480170E-01
Normal-vs-AfricanAmerican
3.288600E-01
Normal-vs-Asian
1.586250E-01
Caucasian-vs-AfricanAmerican
8.907000E-01
Caucasian-vs-Asian
3.703400E-01
AfricanAmerican-vs-Asian
5.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.641760E-01
Normal-vs-Female
1.258380E-01
Male-vs-Female
5.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.304800E-01
Normal-vs-Age(41-60Yrs)
2.160200E-01
Normal-vs-Age(61-80Yrs)
1.153210E-01
Normal-vs-Age(81-100Yrs)
1.397420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.557560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.733900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.626000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.493610E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.206560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.162180E-01
Normal-vs-Daily Drinker
6.272300E-02
Normal-vs-Weekly Drinker
3.272000E-01
Normal-vs-Occasional Drinker
3.574000E-02
Normal-vs-Social Drinker
2.807000E-01
Non Drinker-vs-Daily Drinker
5.582600E-01
Non Drinker-vs-Weekly Drinker
9.760400E-01
Non Drinker-vs-Occasional Drinker
9.641000E-01
Non Drinker-vs-Social Drinker
4.494800E-01
Daily Drinker-vs-Weekly Drinker
7.087600E-01
Daily Drinker-vs-Occasional Drinker
5.039200E-01
Daily Drinker-vs-Social Drinker
2.208000E-01
Weekly Drinker-vs-Occasional Drinker
9.941000E-01
Weekly Drinker-vs-Social Drinker
6.399800E-01
Occasional Drinker-vs-Social Drinker
4.478000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.465580E-01
Normal-vs-Grade 2
2.391600E-02
Normal-vs-Grade 3
5.377900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.312400E-01
Grade 1-vs-Grade 3
1.947030E-01
Grade 1-vs-Grade 4
1.465580E-01
Grade 2-vs-Grade 3
5.740800E-01
Grade 2-vs-Grade 4
2.391600E-02
Grade 3-vs-Grade 4
5.377900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.528570E-01
Normal-vs-NonDiabetic
1.012610E-01
Diabetic-vs-NonDiabetic
7.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.233800E-01
Normal-vs-NoPancreatitis
1.222180E-01
Pancreatitis-vs-NoPancreatitis
6.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.351380E-01
Normal-vs-N1
1.601580E-01
N0-vs-N1
5.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.606630E-01
Normal-vs-TP53-NonMutant
4.158400E-01
TP53-Mutant-vs-TP53-NonMutant
3.854400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
